211 related articles for article (PubMed ID: 17384577)
1. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
[TBL] [Abstract][Full Text] [Related]
2. CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model.
Nguyen-Hoai T; Baldenhofer G; Ahmed MS; Pham-Duc M; Gries M; Lipp M; Dörken B; Pezzutto A; Westermann J
J Gene Med; 2012 Feb; 14(2):128-37. PubMed ID: 22228591
[TBL] [Abstract][Full Text] [Related]
3. CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.
Nguyen-Hoai T; Hohn O; Vu MD; Baldenhofer G; Sayed Ahmed MS; Dörken B; Norley S; Lipp M; Pezzutto A; Westermann J
Cancer Gene Ther; 2012 Dec; 19(12):880-7. PubMed ID: 23099886
[TBL] [Abstract][Full Text] [Related]
4. CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.
Nguyen-Hoai T; Baldenhofer G; Sayed Ahmed MS; Pham-Duc M; Vu MD; Lipp M; Dörken B; Pezzutto A; Westermann J
Cancer Gene Ther; 2012 Jan; 19(1):69-76. PubMed ID: 21997231
[TBL] [Abstract][Full Text] [Related]
5. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann J; Nguyen-Hoai T; Mollweide A; Richter G; Schmetzer O; Kim HJ; Blankenstein T; Dörken B; Pezzutto A
Gene Ther; 2004 Jul; 11(13):1048-56. PubMed ID: 15085174
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
[TBL] [Abstract][Full Text] [Related]
7. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
Eo SK; Lee S; Kumaraguru U; Rouse BT
Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
[TBL] [Abstract][Full Text] [Related]
9. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
10. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.
Walker SR; Ogagan PD; DeAlmeida D; Aboka AM; Barksdale EM
J Pediatr Surg; 2006 Jan; 41(1):260-5. PubMed ID: 16410144
[TBL] [Abstract][Full Text] [Related]
12. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.
Hillinger S; Yang SC; Zhu L; Huang M; Duckett R; Atianzar K; Batra RK; Strieter RM; Dubinett SM; Sharma S
J Immunol; 2003 Dec; 171(12):6457-65. PubMed ID: 14662845
[TBL] [Abstract][Full Text] [Related]
13. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
Lu J; Zhang Q; Liang CM; Xia SJ; Zhong CP; Wang DW
Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352
[TBL] [Abstract][Full Text] [Related]
14. Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine.
Huang CH; Chang CC; Lin CM; Wang ST; Wu MT; Li EI; Chang HC; Lin CC
Cancer Immunol Immunother; 2010 Aug; 59(8):1259-72. PubMed ID: 20390417
[TBL] [Abstract][Full Text] [Related]
15. The mouse chorionic gonadotropin beta-subunit-like (muCG beta l) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CG beta (rmCG beta).
Shi SQ; Peng JP; Xu L; Yang Y; Chen Y
J Gene Med; 2005 Jan; 7(1):87-96. PubMed ID: 15517553
[TBL] [Abstract][Full Text] [Related]
16. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
Marshall DJ; Rudnick KA; McCarthy SG; Mateo LR; Harris MC; McCauley C; Snyder LA
Vaccine; 2006 Jan; 24(3):244-53. PubMed ID: 16135392
[TBL] [Abstract][Full Text] [Related]
18. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
[TBL] [Abstract][Full Text] [Related]
19. Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration.
Humrich JY; Humrich JH; Averbeck M; Thumann P; Termeer C; Kämpgen E; Schuler G; Jenne L
Immunology; 2006 Feb; 117(2):238-47. PubMed ID: 16423060
[TBL] [Abstract][Full Text] [Related]
20. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.
Kawashima D; Oshitani N; Jinno Y; Watanabe K; Nakamura S; Higuchi K; Arakawa T
J Clin Pathol; 2005 Oct; 58(10):1057-63. PubMed ID: 16189151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
